Status:
COMPLETED
Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)
Lead Sponsor:
Ege University
Collaborating Sponsors:
Fresenius Medical Care North America
Conditions:
End-stage Renal Disease
Hemodialysis
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
This study aims to investigate the effects of high flux dialyser use and ultra pure dialysate utilization on cardiovascular disease by evaluating cardiovascular morbidity and mortality, progression of...
Detailed Description
This proposed prospective, randomized, controlled study aims to investigate the effects of high flux dialyser use and ultra pure dialysate utilization on cardiovascular disease by evaluating cardiovas...
Eligibility Criteria
Inclusion
- Aged between 18 and 80 years
- On maintenance bicarbonate hemodialysis scheduled thrice weekly, at least 12 hours/week
- Willingness to participate in the study with a written informed consent.
Exclusion
- To be scheduled for living donor renal transplantation
- To have serious life-limiting co-morbid situations; namely active malignancy, active infection, end-stage cardiac, pulmonary, or hepatic disease; pregnancy or lactating
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
704 Patients enrolled
Trial Details
Trial ID
NCT00295191
Start Date
November 1 2005
End Date
March 1 2010
Last Update
October 4 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
FMC Clinics
Bornova, İzmir, Turkey (Türkiye), 35100
2
Ege University School of Medicine
Bornova-Izmir, Turkey (Türkiye), 35100